Search results for "Mg"

showing 10 items of 492 documents

Multiple roles for ISWI in transcription, chromosome organization and DNA replication.

2003

ISWI functions as the ATPase subunit of multiple chromatin-remodeling complexes. These complexes use the energy of ATP hydrolysis to slide nucleosomes and increase chromatin fluidity, thereby modulating the access of transcription factors and other regulatory proteins to DNA. Here we discuss recent progress toward understanding the biological functions of ISWI, with an emphasis on its roles in transcription, chromosome organization and DNA replication.

DNA ReplicationTranscriptional ActivationHMG-boxTranscription GeneticBiophysicsBiologyBiochemistryATP-dependent chromatin remodeling ISWI Transcription Replication Chromosome structureChromatin remodelingChromosomesAdenosine TriphosphateControl of chromosome duplicationStructural BiologyGeneticsNucleosomeAnimalsHumansTranscription factorGeneticsAdenosine TriphosphatasesDNA replicationChromatin Assembly and DisassemblyChromatinSettore BIO/18 - GeneticaGene Expression RegulationOrigin recognition complexTranscription FactorsBiochimica et biophysica acta
researchProduct

Ultraviolet light-induced apoptotic death is impaired by the HMG-CoA reductase inhibitor lovastatin.

2003

HMG-CoA reductase inhibitors (i.e., statins) attenuate C-terminal isoprenylation of Rho GTPases, thereby inhibiting UV-C-induced activation of c-Jun-N-terminal kinases/stress-activated protein kinases (JNKs/SAPKs). Inhibition of UV-C-triggered JNK/SAPK activation by lovastatin is due to inhibition of Rac-SEK1/MKK4-mediated phosphorylation of JNKs/SAPKs at Thr183/Tyr185. UV-C-stimulated phosphorylation of p38 kinase (Thr180/Tyr182) is also impaired by lovastatin. Cell killing provoked by UV-C irradiation was significantly inhibited by lovastatin. This was paralleled by a reduced frequency of chromosomal aberrations, accelerated recovery from UV-C-induced transient replication blockage, inhib…

DNA ReplicationUltraviolet Raysp38 mitogen-activated protein kinasesBiophysicsApoptosisCHO CellsBiochemistryp38 Mitogen-Activated Protein KinasesCricetinaemedicineUltraviolet lightAnimalsMitogen-Activated Protein Kinase 8LovastatinMolecular BiologyCaspasebiologyKinaseCell BiologyCell biologyrac GTP-Binding ProteinsEnzyme ActivationCell killingApoptosisCaspasesHMG-CoA reductasebiology.proteinLovastatinHydroxymethylglutaryl-CoA Reductase InhibitorsMitogen-Activated Protein Kinasesmedicine.drugBiochemical and biophysical research communications
researchProduct

Hypogonadism in β-thalassemic adolescents: A characteristic pituitary-gonadal impairment. The ineffectiveness of long-term iron chelation therapy

1990

The pituitary-gonadal function was studied in 18 beta-thalassemic female adolescents, 8 with delayed puberty and 10 with primary amenorrhea,treated with repeated transfusions and long-term iron chelation therapy by subcutaneous infusion. A 100 micrograms gonadotropin-releasing hormone (GnRH) test, a double-bolus GnRH test after estradiol administration in non-responders, a 400 micrograms thyrotropin-releasing hormone (TRH) test and a 'high dose' human menopausal gonadotropin (hMG) test were performed. LH and FSH peak levels were significantly lower in thalassemic patients than in controls, both in the 100 micrograms GnRH test (LH was 4.3 +/- 0.7 mIU/ml vs 40.8 +/- 6.0 mIU/ml and FSH 3.3 +/-…

Delayed pubertyendocrine systemmedicine.medical_specialtyMenotropinsAdolescentendocrine system diseasesmedicine.drug_classIronEndocrinology Diabetes and MetabolismDeferoxamineGonadotropin-Releasing HormoneGnrh testEndocrinologyTRH stimulation testInternal medicinemedicineHumansChildThyrotropin-Releasing HormoneDose-Response Relationship DrugEstradiolbiologybusiness.industryHypogonadismOvaryObstetrics and GynecologyIron chelation therapyLuteinizing HormoneChelation TherapyProlactinProlactinEndocrinologyPituitary GlandHMG-CoA reductasebiology.proteinThalassemiaFemaleFollicle Stimulating Hormonemedicine.symptomGonadotropinbusinesshormones hormone substitutes and hormone antagonistsHormoneGynecological Endocrinology
researchProduct

Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging

2013

Cardiac magnetic resonance (CMR) is considered an useful method in the evaluation of many cardiac disorders. Based on our experience and available literature, we wrote a document as a guiding tool in the clinical use of CMR. Synthetically we describe different cardiac disorders and express for each one a classification, I to IV, depending on the significance of diagnostic information expected.

Diagnostic informationmedicine.medical_specialtyContrast MediamedicineHumansRadiology Nuclear Medicine and imagingHeart; Mgnetic resonanceCardiac disordersCardiac imagingNeuroradiologymedicine.diagnostic_testbusiness.industryHeartMagnetic resonance imagingInterventional radiologyGeneral MedicineMagnetic Resonance ImagingItalyMagnetic resonanceCardiovascular Diseasescardiovascular systemRadiologyheart; magnetic resonanceSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessNuclear medicineCardiac magnetic resonanceMgnetic resonanceLa radiologia medica
researchProduct

Kurzemes un Zemgales hercogiste no 1561. - 1795.gadam latviešu historiogrāfijas vērtējumā

2018

Bakalaura darbs ir uzrakstīts ar mērķi analizēt Kurzemes un Zemgales hercogistes vēstures atspoguļojumu latviešu historiogrāfijā un apzināt vērtējumu galvenās tendences. Darbs veidots, ievērojot hronoloģiskos atskaites punktus, sākot ar hercogistes izveidošanos 1561.gadā un beidzot ar hercogistes inkorporāciju Krievijas impērijā 1795.gadā, atsevišķas nodaļas veltot galvenajai problēmai visā hercogistes pastāvēšanas laikā, proti hercogu cīņai ar muižniecību par varu un hercogu cīņai par dinastijas saglabāšanu un hercogistes pastāvēšanu. Analizējot zināmākā hercoga Jēkaba personības un darbības aprakstu un vērtējumu 20.gs. 20. – 30.gadu, trimdas un mūsdienu latviešu autoru darbos, tika konsta…

Different periods of Latvian historiographyInkorporācijaVēstureKurzemes - Zemgales hercogisteDuchy of Courland and SemigalliaDažādu posmu latviešu historiogrāfija
researchProduct

About the reliability of the Maximum Entropy Method in reconstructing electron density: the case of MgO

2006

Abstract The reliability of the Maximum Entropy Method (MEM) to reconstruct finite temperature electron density (ED) is here discussed, investigating the case of periclase (MgO). A theoretical electron density has been generated by quantum mechanic calculations and folded with a function simulating atomic thermal motion, in order to produce a reference errorless ED [ρ(r)REF]. The Fourier coefficients of ρ(r)REF have been calculated, and used as “observed” diffraction intensities to reconstruct via MEM the original ED. The electron density attained by MEM [ρ(r)MEM] and ρ(r)REF have been compared with each other (pixel-by-pixel and critical points) to assess the ability of MEM to retrieve EDs…

DiffractionElectron densityYield (engineering)Basis (linear algebra)ChemistrypericlaseMaximum Entropy MethodMEMMgOFunction (mathematics)Condensed Matter PhysicsMEM; Maximum Entropy Method; electron density; periclase; MgOInorganic ChemistryTheoretical physicsOrder (group theory)General Materials Scienceelectron densityAtomic physicsFourier seriesQuantumZeitschrift für Kristallographie - Crystalline Materials
researchProduct

Kinetics of dimer F2 type center annealing in MgF2 crystals

2018

Authors are greatly indebted to V. Lisitsyn, A. Ch. Lushchik and R.Vila for stimulating discussions. This work has been carried out within the framework of the EUROfusion Consortium and has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 633053. The views and opinions expressed herein do not necessarily reflect those of the European Commission. The calculations were performed using facilities of the Stuttgart Supercomputer Center (project DEFTD 12939).

DiffusionAnnealing kinetics:NATURAL SCIENCES:Physics [Research Subject Categories]MgF2F2 centersRadiation defectsF centers
researchProduct

A Newman property for BLD-mappings

2019

We define a Newman property for BLD-mappings and prove that for a BLD-mapping between generalized manifolds equipped with complete path-metrics, this property is equivalent to the branch set being porous when the codomain is LLC. peerReviewed

Discrete mathematicsProperty (philosophy)BLD-mappings010102 general mathematicsMetric Geometry (math.MG)30L10 30C65 57M1216. Peace & justice01 natural sciences010101 applied mathematicsSet (abstract data type)Mathematics - Metric GeometryPath (graph theory)FOS: MathematicsGeometry and Topologygeometria0101 mathematicsMathematics
researchProduct

Local dimensions of measures on infinitely generated self-affine sets

2014

We show the existence of the local dimension of an invariant probability measure on an infinitely generated self-affine set, for almost all translations. This implies that an ergodic probability measure is exactly dimensional. Furthermore the local dimension equals the minimum of the local Lyapunov dimension and the dimension of the space. We also give an estimate, that holds for all translation vectors, with only assuming the affine maps to be contractive.

Discrete mathematicsmatematiikka28A80Applied Mathematicsta111Minkowski–Bouligand dimensionDimension functionMetric Geometry (math.MG)Dynamical Systems (math.DS)Complex dimensionEffective dimensionPacking dimensionMathematics - Metric GeometryHausdorff dimensionFOS: MathematicsdimensionsMathematics - Dynamical SystemsDimension theory (algebra)Inductive dimensionulottuvuudetAnalysisMathematicsJournal of Mathematical Analysis and Applications
researchProduct

Combined pharmacological treatment of heterozygous familial hypercholesterolemia

1990

Combined therapy of heterozygous familial hypercholesterolemia using a non-systemically acting drug (bile acid sequestrants) and a systemically acting one is frequently employed in clinical practice. A brief review of this topic is presented, with particular emphasis on the use of cholestyramine combined with pravastatin, a new HMG CoA reductase inhibitor.

DrugCholestyramineBile acidbiologymedicine.drug_classbusiness.industrymedia_common.quotation_subjectnutritional and metabolic diseasesFamilial hypercholesterolemiaMevalonic acidPharmacologymedicine.diseasePharmacological treatmentchemistry.chemical_compoundchemistryHMG-CoA reductasemedicinebiology.proteinbusinessPravastatinmedicine.drugmedia_common
researchProduct